231 related articles for article (PubMed ID: 35874667)
1. Hepatocyte-Conditional Knockout of Phosphatidylethanolamine Binding Protein 4 Aggravated LPS/D-GalN-Induced Acute Liver Injury
Qu XQ; Chen QF; Shi QQ; Luo QQ; Zheng SY; Li YH; Bai LY; Gan S; Zhou XY
Front Immunol; 2022; 13():901566. PubMed ID: 35874667
[TBL] [Abstract][Full Text] [Related]
2. 4-hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice.
Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
Int Immunopharmacol; 2020 Jun; 83():106445. PubMed ID: 32272395
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.
Tian Y; Li Z; Shen B; Zhang Q; Feng H
Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the NF-κB signaling pathway.
Luo Q; Ling Y; Li Y; Qu X; Shi Q; Zheng S; Li Y; Huang Y; Zhou X
Front Pharmacol; 2022; 13():964829. PubMed ID: 36120358
[TBL] [Abstract][Full Text] [Related]
6. Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway.
Zhang Z; Tian L; Jiang K
Int Immunopharmacol; 2019 Dec; 77():105974. PubMed ID: 31735662
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of Toll-like receptor 4 pathway by TAK242 protects the liver in sepsis].
Yang M; Liu Z; Xu Z; Yang K; Li X; Bai X; Peng P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Aug; 34(8):814-818. PubMed ID: 36177923
[TBL] [Abstract][Full Text] [Related]
8. CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes.
Urbanik T; Koehler BC; Wolpert L; Elßner C; Scherr AL; Longerich T; Kautz N; Welte S; Hövelmeyer N; Jäger D; Waisman A; Schulze-Bergkamen H
World J Gastroenterol; 2014 Dec; 20(45):17049-64. PubMed ID: 25493017
[TBL] [Abstract][Full Text] [Related]
9. Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis.
Chen SN; Tan Y; Xiao XC; Li Q; Wu Q; Peng YY; Ren J; Dong ML
Acta Pharmacol Sin; 2021 Oct; 42(10):1610-1619. PubMed ID: 33495514
[TBL] [Abstract][Full Text] [Related]
10. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
[TBL] [Abstract][Full Text] [Related]
11. Methyl 3,4-dihydroxybenzoate protects against d-galN/LPS-induced acute liver injury by inhibiting inflammation and apoptosis in mice.
Wang X; Wu L; Zhang Q; Li L; Xie Y; Wan X; Wu H; Xiang Y
J Pharm Pharmacol; 2019 Jul; 71(7):1082-1088. PubMed ID: 31032922
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
Tao YC; Wang ML; Wu DB; Luo C; Tang H; Chen EQ
J Transl Med; 2019 May; 17(1):151. PubMed ID: 31077206
[TBL] [Abstract][Full Text] [Related]
13. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
[TBL] [Abstract][Full Text] [Related]
14. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways.
Tang F; Fan K; Wang K; Bian C
Biomed Pharmacother; 2019 Mar; 111():527-536. PubMed ID: 30597306
[TBL] [Abstract][Full Text] [Related]
15. β-arrestin 2 attenuates lipopolysaccharide-induced liver injury
Jiang MP; Xu C; Guo YW; Luo QJ; Li L; Liu HL; Jiang J; Chen HX; Wei XQ
World J Gastroenterol; 2018 Jan; 24(2):216-225. PubMed ID: 29375207
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the crosstalk between Keap1/Nrf2/HO-1 and NF-κB signaling pathways by Tomatidine protects against inflammation/oxidative stress-driven fulminant hepatic failure in mice.
Abdulaal WH; Omar UM; Zeyadi M; El-Agamy DS; Alhakamy NA; Ibrahim SRM; Almalki NAR; Asfour HZ; Al-Rabia MW; Mohamed GA; Elshal M
Int Immunopharmacol; 2024 Mar; 130():111732. PubMed ID: 38402834
[TBL] [Abstract][Full Text] [Related]
18. Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
Jia YN; Lu HP; Peng YL; Zhang BS; Gong XB; Su J; Zhou Y; Pan MH; Xu L
Int Immunopharmacol; 2018 Mar; 56():105-112. PubMed ID: 29414639
[TBL] [Abstract][Full Text] [Related]
19. Polysaccharides from Tetrastigma Hemsleyanum Diels et Gilg attenuate LPS-induced acute lung injury by modulating TLR4/COX-2/NF-κB signaling pathway.
Wang B; Lin Y; Zhou M; Fu S; Zhu B; Chen Y; Ding Z; Zhou F
Biomed Pharmacother; 2022 Nov; 155():113755. PubMed ID: 36182735
[TBL] [Abstract][Full Text] [Related]
20. Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response.
Yang W; Tao K; Zhang P; Chen X; Sun X; Li R
Biochem Pharmacol; 2022 Jan; 195():114863. PubMed ID: 34861244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
